Full-Time

Quality Assurance Specialist

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Mid

Chicago, IL, USA

Hybrid position requiring in-office presence.

Category
QA & Testing
Quality Assurance
Requirements
  • Superb organizational and follow through skills
  • Strong interpersonal skills in the areas of written and verbal communication
  • Must be creative, flexible, and able to prioritize and handle multiple projects concurrently
  • Must be self-motivated and have the ability to work with minimal supervision
  • Minimum of 4 years of QMS experience in the FDA regulated industry - medical devices or IVDs
  • Bachelor’s degree required preferably in a life science discipline
Responsibilities
  • Support Lead Auditor with audit functions
  • Participate in conducting internal audits under the direction of the Lead Auditor
  • Assist with completion of partnership pre-audit questionnaires
  • Oversee drafting of internal and external audit responses to closure
  • Administrative audit functions as needed
  • Lead partnership/client audits.
  • Communicate with partners as needed
  • Assist with client pre-qualification questionnaires regarding quality assurance (QA) and the quality management system (QMS).
  • Assist with completion of Declaration of Conformity (EC DoC) of products
  • Communication with Tempus’ Notified Body as needed
  • Comply with documented Quality Management System procedures
  • Completion of assigned training on time
  • Perform other duties and projects as assigned
  • Review QMS documentation against applicable regulations for international compliance
  • Remain up to date with applicable regulations to communicate changing requirements to Management
  • Assist with inspection readiness efforts and external audits
  • Offer improvement strategies to existing processes
  • Managing and hosting external audits including regulatory inspections and CAP/CLIA Inspections.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

5%

1 year growth

15%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.

Help us improve and share your feedback! Did you find this helpful?